Research advancement in the tumor biomarker of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the third most common cause of mortality due to malignancy next to gastric cancer and esophageal cancer. Several causal factors have been proposed to be involved in the pathogenesis of HCC including regional and age difference, hepatitis virus, aflatoxin, chemicals,...
Main Authors: | Qing Du, Xiaoying Ji, Guangjing Yin, Dengxian Wei, Pengcheng Lin, Yongchang Lu, Yugui Li, Qiaohong Yang, Shizhu Liu, Jinliang Ku, Wenbin Guan, Yuanzhi Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Cancer Translational Medicine |
Subjects: | |
Online Access: | http://www.cancertm.com/article.asp?issn=2395-3977;year=2018;volume=4;issue=6;spage=153;epage=162;aulast=Du |
Similar Items
-
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
by: Gok Yavuz B, et al.
Published: (2021-09-01) -
The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma
by: Yonghui Wang, et al.
Published: (2020-01-01) -
Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
by: Hsu CH, et al.
Published: (2014-06-01) -
Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
by: Wen-Jing Su, et al.
Published: (2021-01-01) -
Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study
by: Dongming Liu, et al.
Published: (2021-02-01)